Long-term vaping may damage lung immune cells, warn researchers

Image
IANS London
Last Updated : Aug 14 2018 | 3:00 PM IST

With vaping becoming a style statement globally including in India, a small yet significant study has found that vaporisers may potentially disable key immune cells in the lung and boosts inflammation if used for long.

The e-cigarette vapour boosts the production of inflammatory chemicals and disables key protective cells in the lung that keep the air spaces clear of potentially harmful particles, revealed the study published online in the journal Thorax.

Vaporisers are different from traditional e-cigarettes in terms of the range of flavours, mixing, better user control and large battery use.

According to Professor David Thickett from Britain's University of Birmingham, many e-cigarette companies have been bought up by the tobacco giants, "and there's certainly an agenda to portray e-cigarettes as safe".

While e-cigarettes are safer than traditional cigarettes, they may still be harmful in the long term, Thickett explained as the current body of research is in its infancy and not able to answer that question yet.

"In terms of cancer causing molecules in cigarette smoke, as opposed to cigarette vapour, there are certainly reduced numbers of carcinogens. They are safer in terms of cancer risk, but if you vape for 20 or 30 years and this can cause COPD, then that's something we need to know about," he stated.

"I don't believe e-cigarettes are more harmful than ordinary cigarettes," he said, adding that "But we should have a cautious scepticism that they are as safe as we are being led to believe."

Although vaping is increasing in popularity, most of the current body of research has focused only on the chemical composition of e-cigarette liquid before it is vaped.

However, the study stated that the effects are similar to those seen in regular smokers and patients with chronic lung disease.

It showed that the vaping process itself could damage vital immune system cells, at least under laboratory conditions.

According to Thickett, the vapour produced by an e-cigarette boosts the production of inflammatory chemicals and disables key protective cells in the lung that keep the air spaces clear of potentially harmful particles.

The vapour then impairs the activity of alveolar macrophages -- which engulf and remove dust particles, bacteria -- and allergens that have evaded the other mechanical defences of the respiratory tract.

The findings suggested that while further research is needed to better understand the long-term health impact of vaping on people, e-cigarette vapour may be more harmful than we think.

--IANS

rt-in/na/sed

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 14 2018 | 2:56 PM IST

Next Story